Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tadashi MIYATAKE
Pharmacokinetics and Safety of EST, a New Thiol Protease Inhibitor in Patients With Muscle Diseases.
Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
Related publications
Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase a in Patients With Fabry Disease
Journal of Inherited Metabolic Disease
Genetics
A New Class of Serine and Cysteine Protease Inhibitor With Chemotherapeutic Potential.
Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986142, a Novel Reversible BTK Inhibitor, in Healthy Participants
European Journal of Clinical Pharmacology
Medicine
Pharmacology
Antipain, a New Protease Inhibitor Isolated From Agtinomycetes
Journal of Antibiotics
Drug Discovery
Pharmacology
Bioavailability and Pharmacokinetics of Oral Topotecan: A New Topoisomerase I Inhibitor
British Journal of Cancer
Cancer Research
Oncology
Effects of Thiol Protease Inhibitors on Cell Cycle and Proliferation of Vascular Smooth Muscle Cells in Culture
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Safety, Efficacy, and Pharmacokinetics of Intravenous C1 Esterase Inhibitor (Human) Prophylaxis in Children With Hereditary Angioedema (HAE)
Journal of Allergy and Clinical Immunology
Allergy
Immunology
Safety of a Cyclooxygenase-2 Inhibitor in Patients With Aspirin-Sensitive Asthma
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Safety and Pharmacokinetics of Amprenavir (141W94), a Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor, Following Oral Administration of Single Doses to HIV-Infected Adults
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
